among
patient
hospit
acut
cardiorespiratori
failur
abstract
object
document
preval
respiratori
viru
infect
patient
chronic
cardiac
pulmonari
disord
admit
critic
care
unit
acut
cardiorespiratori
failur
design
set
patient
studi
took
place
critic
care
unit
two
consecut
winter
patient
admit
unit
acut
respiratori
cardiac
failur
enrol
nasal
swab
taken
polymeras
chain
reaction
pcr
detect
influenza
viru
respiratori
syncyti
viru
rsv
metapneumoviru
rhinoviru
coronaviru
result
one
hundr
twentytwo
patient
enrol
mean
age
year
patient
femal
new
simplifi
acut
physiolog
score
sap
ii
score
admiss
patient
acut
respiratori
failur
report
influenzalik
ill
admiss
patient
die
unit
twentyon
patient
test
posit
respiratori
viru
posit
rate
influenza
viru
rsv
rhinoviru
metapneumoviru
coronaviru
link
found
virolog
result
clinic
outcom
strong
link
found
rate
influenza
viru
posit
incid
flulik
ill
commun
conclus
result
show
respiratori
viru
infectionparticularli
influenza
viru
infect
epidem
periodsi
introduct
respiratori
virus
particularli
influenza
viru
respiratori
syncyti
viru
rsv
often
describ
potenti
trigger
acut
respiratori
cardiac
failur
frail
individu
studi
elderli
peopl
hospit
acut
cardiopulmonari
disord
influenzalik
ill
influenza
diagnos
case
rsv
infect
case
respiratori
pathogen
rhinovirus
coronavirus
human
metapneumovirus
rare
studi
set
data
suggest
high
preval
infect
respect
frequenc
pathogen
patient
admit
critic
care
unit
ccu
previous
report
object
document
preval
respiratori
viru
infect
patient
chronic
cardiac
pulmonari
disord
admit
ccu
acut
respiratori
cardiac
failur
studi
took
place
ccu
locat
univers
hospit
pari
institut
review
board
french
societi
critic
care
medicin
approv
studi
protocol
enrol
patient
admit
ccu
octob
march
novemb
februari
acut
respiratori
cardiac
failur
chronic
cardiac
pulmonari
disord
warrant
specif
treatment
exclus
criteria
appli
enrol
took
place
monday
friday
two
nasal
swab
sampl
collect
store
ml
viral
transport
medium
prepar
virolog
laboratori
one
ml
transport
medium
contain
mg
tryptos
phosphat
broth
mg
gelatin
beckton
dickinson
le
pont
de
claix
franc
unit
penicillin
mg
streptomycin
g
amphotericin
b
antibiot
antimycot
solut
sigma
saint
quentin
fallavi
franc
demograph
data
medic
histori
hospit
cours
discharg
diagnosi
collect
prospect
case
screen
respiratori
virus
base
reversetranscript
polymeras
chain
reaction
amplif
rtpcr
viral
rna
extract
l
nasal
swab
sampl
qiagen
viral
rna
extract
kit
qiagen
courtaboeuf
franc
realtim
amplif
perform
cdna
synthesi
random
hexam
includ
applera
rt
rna
transcript
kit
courtaboeuf
franc
previous
describ
use
previous
describ
primer
probe
amplifi
influenza
viru
influenza
b
viru
rsv
b
metapneumoviru
quantif
achiev
use
cycl
threshold
ct
valu
ct
valu
grade
weak
medium
strong
posit
respect
convent
rtpcr
method
use
coronaviru
e
coronaviru
rhinoviru
pcr
amplif
done
use
titan
onetub
rtpcr
system
roch
diagnost
meylan
franc
primer
describ
pitkaranta
et
al
applera
thermocycl
nest
pcr
use
rhinoviru
detect
specif
inner
primer
atg
agg
ata
tgc
ttt
aca
ccc
aaa
gta
posit
neg
control
test
run
data
influenzalik
ill
pari
surround
area
iledefr
use
surrog
influenza
viru
infect
commun
obtain
french
sentinel
network
studi
period
chosen
encompass
annual
influenzalik
ill
epidem
kruskalw
test
use
continu
variabl
fisher
exact
test
use
categor
variabl
univari
logist
regress
model
use
examin
link
weekli
incid
flulik
ill
commun
independ
variabl
rate
influenza
viru
posit
ccu
depend
variabl
pvalu
consid
statist
signific
seventyf
patient
admit
ccu
first
period
patient
admit
second
period
enrol
studi
patient
admit
directli
ccu
significantli
women
first
period
second
period
vs
demograph
clinic
characterist
patient
enrol
two
winter
similar
mean
age
year
standard
deviat
sd
new
simplifi
acut
physiolog
score
sap
ii
sd
see
tabl
twentythre
percent
patient
receiv
treatment
heart
diseas
respiratori
diseas
chronic
respiratori
disord
chronic
respiratori
failur
asthma
lung
cancer
three
disord
five
cardiac
disord
ischem
heart
diseas
patient
hypertens
chronic
heart
failur
atrial
fibril
seven
valvular
diseas
two
cardiac
disord
nine
twentytwo
percent
patient
receiv
inhal
corticosteroid
ninetyfour
percent
patient
admit
acut
respiratori
failur
acut
cardiac
failur
main
admiss
diagnos
acut
exacerb
chronic
respiratori
failur
nonchron
obstruct
pulmo
nari
diseas
copd
relat
acut
lung
injuri
sever
asthma
pneumonia
acut
pulmonari
edema
six
cardiogen
shock
four
cardiorespiratori
disord
four
fourteen
percent
patient
recal
flulik
symptom
within
day
prior
ccu
admiss
three
patient
pcrposit
two
influenza
one
rsv
three
patient
bacteri
pneumonia
twp
streptococcu
pneumonia
one
haemophilu
influenza
thirtyf
percent
patient
state
receiv
latest
influenza
vaccin
thirteen
patient
die
ccu
median
length
ccu
stay
day
interquartil
rang
day
nine
patient
pcrposit
respiratori
viru
first
period
four
rsv
two
rhinoviru
two
metapneumovirus
one
influenza
patient
posit
second
period
seven
influenza
two
rsv
two
rhinoviru
one
coronaviru
see
fig
sampl
collect
within
h
h
h
admiss
case
interv
admiss
sampl
collect
influenc
virolog
result
one
rsvand
influenzaposit
sampl
grade
strongli
posit
one
influenzaposit
sampl
grade
medium
posit
two
metapneumovirusposit
sampl
grade
weakli
posit
link
found
virolog
result
demograph
characterist
clinic
outcom
tabl
one
influenzaposit
patient
vaccin
compar
influenzaneg
patient
likelihood
influenza
viru
posit
given
week
increas
ci
incid
flulik
ill
commun
increas
one
point
per
inhabit
week
increas
ci
incid
increas
one
point
per
inhabit
age
year
older
studi
show
respiratori
virus
detect
highli
sensit
method
common
among
patient
admit
cardiorespiratori
failur
one
four
patient
admit
epidem
period
flulik
ill
posit
virus
signific
posit
respiratori
viru
pcr
test
debat
literatur
data
indic
chronic
shed
carriag
respiratori
viru
rna
immunocompet
individu
noteworthi
influenza
viru
rna
longer
detect
sampl
collect
day
diseas
onset
rhinoviru
rna
correspond
interv
week
individu
never
exce
week
find
suggest
pcrposit
patient
infect
recent
within
week
admiss
howev
patient
stabl
copd
may
transient
colon
rsv
although
viral
load
lower
acut
infect
use
quantit
score
system
found
rsvposit
sampl
strongli
posit
support
probabl
rsv
posit
relat
acut
viral
infect
airway
cumul
incid
influenzalik
ill
individu
age
year
older
two
period
studi
respect
rate
pcr
posit
influenza
viru
second
period
p
compar
adjust
age
therefor
believ
pcrposit
patient
infect
higher
expect
frequenc
indic
posit
associ
infect
acut
respiratori
cardiac
failur
rate
influenza
rsv
infect
consist
influenza
posit
rsv
posit
observ
prospect
survey
elderli
patient
chronic
cardiorespiratori
diseas
hospit
gener
medicalsurg
hospit
fig
virolog
test
patient
admit
critic
care
unit
acut
respiratori
cardiac
failur
weekli
influenzalik
ill
incid
commun
acut
cardiopulmonari
condit
mechan
infect
may
caus
acut
respiratori
cardiac
failur
studi
howev
causal
relationship
influenza
viru
infect
hospit
respiratori
cardiac
diseas
detect
vaccin
effect
studi
show
influenza
immun
reduc
hospit
seem
like
respiratori
virus
capac
trigger
sever
ill
patient
underli
chronic
condit
call
explanatori
studi
lead
increas
vigil
infect
final
although
differ
signific
probabl
owe
small
number
posit
patient
higher
rate
pcr
posit
among
unvaccin
patient
support
influenza
vaccin
frail
individu
result
also
call
better
treatment
prevent
infect
respiratori
pathogen
wider
influenza
vaccin
coverag
elderli
highrisk
adult
increas
use
antivir
influenza
treatment
contact
prophylaxi
develop
new
treatment
vaccin
rsv
infect
